Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholder Deficit

v3.19.2
Condensed Consolidated Statement of Changes in Stockholder Deficit - USD ($)
Common Stock [Member]
Additional Paid-In-Capital [Member]
Deferred Compensation [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 122,675 $ 56,401,069 $ (10,125) $ (57,919,096) $ (1,405,477)
Balance, shares at Dec. 31, 2017 122,674,516        
Common stock grants to independent directors $ 469 112,031 112,500
Common stock grants to independent directors, shares 469,274        
Deferred compensation 10,125 10,125
Deferred compensation, shares        
Stock option exercises - cashless $ 157 (157)
Stock option exercises - cashless, shares 156,997        
Stock based compensation - options 140,062 140,062
Net loss (2,147,985) (2,147,985)
Balance at Jun. 30, 2018 $ 123,301 56,653,005 (60,067,081) (3,290,775)
Balance, shares at Jun. 30, 2018 123,300,787        
Balance at Dec. 31, 2017 $ 122,675 56,401,069 (10,125) (57,919,096) $ (1,405,477)
Balance, shares at Dec. 31, 2017 122,674,516        
Stock option exercises - cashless, shares         200,000
Balance at Dec. 31, 2018 $ 133,889 58,274,038 (61,943,318) $ (3,535,391)
Balance, shares at Dec. 31, 2018 133,888,573        
Balance at Mar. 31, 2018 $ 122,860 56,520,383 (58,966,959) (2,323,716)
Balance, shares at Mar. 31, 2018 122,859,700        
Common stock grants to independent directors $ 284 62,216 62,500
Common stock grants to independent directors, shares 284,090        
Deferred compensation
Deferred compensation, shares        
Stock option exercises - cashless $ 157 (157)
Stock option exercises - cashless, shares 156,997        
Stock based compensation - options 70,563 70,563
Net loss (1,100,122) (1,100,122)
Balance at Jun. 30, 2018 $ 123,301 56,653,005 (60,067,081) (3,290,775)
Balance, shares at Jun. 30, 2018 123,300,787        
Balance at Dec. 31, 2018 $ 133,889 58,274,038 (61,943,318) (3,535,391)
Balance, shares at Dec. 31, 2018 133,888,573        
Common stock grants to independent directors $ 1,044 173,956 175,000
Common stock grants to independent directors, shares 1,043,858        
Stock based compensation - options 173,000 173,000
Common stock grant to service providers $ 75 10,987 11,062
Common stock grant to service providers, shares 75,000        
Restricted stock issuances $ 1,633 243,367 245,000
Restricted stock issuances, shares 1,633,330        
Issuance of warrants attached to a convertible note 33,300 33,300
Net loss (2,217,114) (2,217,114)
Balance at Jun. 30, 2019 $ 136,641 58,908,648 (64,160,432) (5,115,143)
Balance, shares at Jun. 30, 2019 136,640,761        
Balance at Mar. 31, 2019 $ 134,687 58,498,615 (61,943,318) (3,310,016)
Balance, shares at Mar. 31, 2019 134,686,596        
Common stock grants to independent directors $ 583 86,917 87,500
Common stock grants to independent directors, shares 583,333        
Stock based compensation - options 86,500 86,500
Common stock grant to service providers $ 38 4,649 4,687
Common stock grant to service providers, shares 37,500        
Restricted stock issuances $ 1,333 198,667 200,000
Restricted stock issuances, shares 1,333,332        
Issuance of warrants attached to a convertible note 33,300 33,300
Net loss (2,217,114) (1,081,694)
Balance at Jun. 30, 2019 $ 136,641 $ 58,908,648 $ (64,160,432) $ (5,115,143)
Balance, shares at Jun. 30, 2019 136,640,761